Erenumab-Aooe, also known by its brand name Aimovig, is a prescription medication used for the preventive treatment of migraine headaches in adults. It belongs to a class of drugs called calcitonin gene-related peptide (CGRP) receptor antagonists, which work by blocking the activity of CGRP, a protein that is believed to play a key role in the development of migraines.

This medication is administered as a monthly injection and has been shown to significantly reduce the frequency and severity of migraine attacks in clinical trials. It is important to note that Erenumab-Aooe is not intended for the treatment of acute migraines and should not be used to relieve migraine symptoms once they have already started.

As with any medication, Erenumab-Aooe may cause side effects in some individuals. Common side effects may include injection site reactions, constipation, and muscle cramps. It is important to discuss any potential side effects with your healthcare provider before starting this medication.

It is also important to follow your healthcare provider’s instructions carefully when using Erenumab-Aooe. This medication should be stored in the refrigerator and brought to room temperature before use. Your healthcare provider will show you how to properly administer the injection, which is typically given in the abdomen, thigh, or upper arm.

If you suffer from frequent migraines and have not found relief with other treatments, Erenumab-Aooe may be a viable option for you. Talk to your healthcare provider to see if this medication is right for you and to discuss any questions or concerns you may have.